Shares of Novo Nordisk plunged after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer's ...
New research shows that dementia risk is best predicted by combining genetic vulnerability with cardiovascular disease ...
Combining genetic risk with cardiovascular disease risk factors — such as high LDL cholesterol, obesity, and hypertension — ...
22hon MSN
Analysts, investors say Alzheimer's miss adds to Novo's challenges, but fundamentals intact
Novo Nordisk said on Monday that two late-stage trials testing an older oral version of its semaglutide drug failed to meet ...
Combining genetic risk with cardiovascular disease risk factors—such as high LDL cholesterol, obesity, and hypertension—may ...
On 12 November 2025, Bristol-Myers Squibb conducted a Phase 3 study to Evaluate the Efficacy and Safety of KarXT + KarX-EC ...
FOX6 News Milwaukee on MSN
Inside memory care: Wisconsin push for more regulation
The Wisconsin Chapter of the Alzheimer's Association wants "truth-in-advertising" legislation for facilities that advertise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback